跳转至内容
Merck
CN
  • Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia.

Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia.

Leukemia & lymphoma (2011-12-15)
Jeffrey A Jones, Eric H Kraut, Deidre Deam, John C Byrd, Michael R Grever